Alternatives · ranked by WeighScore
Alternatives to Vyora Wellness
Vyora Wellness grades C (60.5/100), #358 of 544 on our scorecard. Here are the other providers we've graded on the same six dimensions — ranked by WeighScore, highest first.
You're comparing against
Vyora Wellness →Our top-graded alternative
CoreAge Rx leads the full scorecard.
Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
More alternatives, ranked
iThriveMD is a longevity and metabolic-health clinic (physical locations plus telehealth) offering compounded GLP-1 weight loss — semaglutide (from $299/mo) and tirzepatide (from $399/mo), plus microdosing tirzepatide programs — alongside hormone therapy (HRT/TRT), NAD+, peptides, IV therapy, sexual health, and diagnostic lab testing.
Fella Health is a medication weight loss program built specifically for men, offering compounded GLP-1 treatments (semaglutide and tirzepatide) plus free 1:1 health coaching, board-certified clinician care, and a 6-month money-back guarantee.
Prime Health (joinprimehealth.com) is a LegitScript-certified GLP-1 telehealth platform offering compounded semaglutide and tirzepatide for weight loss.
tru Weight Loss (truhealthnow) is a physician-directed telehealth program prescribing compounded semaglutide and tirzepatide, shipped from US-licensed compounding pharmacies.
Nucore Health is a physician-owned, LegitScript-certified telehealth platform serving all 50 states, focused on GLP-1 and longevity care: compounded semaglutide and tirzepatide (including a microdose tirzepatide protocol), plus NAD+, sermorelin and MIC B12.
The 6 above are the closest matches to Vyora Wellness on the WeighScore. Every provider we grade — all 544 of them — is scored on the same six factors: browse every graded provider.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.